Single User License
INR 96810
Site License
INR 193620
Corporate User License
INR 290430

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Genocea Biosciences, Inc.-Product Pipeline Review-2015

Genocea Biosciences, Inc.-Product Pipeline Review-2015


  • Products Id :- GMDHC07444CDB
  • |
  • Pages: 30
  • |
  • August 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Genocea Biosciences, Inc.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Genocea Biosciences, Inc.-Product Pipeline Review-2015', provides an overview of the Genocea Biosciences, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Genocea Biosciences, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Genocea Biosciences, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Genocea Biosciences, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Genocea Biosciences, Inc.'s pipeline products

Reasons To Buy

Evaluate Genocea Biosciences, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Genocea Biosciences, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Genocea Biosciences, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Genocea Biosciences, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Genocea Biosciences, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Genocea Biosciences, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Genocea Biosciences, Inc. Snapshot 5

Genocea Biosciences, Inc. Overview 5

Key Information 5

Key Facts 5

Genocea Biosciences, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Genocea Biosciences, Inc.-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Genocea Biosciences, Inc.-Pipeline Products Glance 10

Genocea Biosciences, Inc.-Clinical Stage Pipeline Products 10

Phase II Products/Combination Treatment Modalities 10

Genocea Biosciences, Inc.-Early Stage Pipeline Products 11

Preclinical Products/Combination Treatment Modalities 11

Discovery Products/Combination Treatment Modalities 12

Genocea Biosciences, Inc.-Drug Profiles 13

GEN-003 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

GEN-004 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

GEN-001 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

GEN-002 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

GEN-005 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Vaccine for Cancer 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

Genocea Biosciences, Inc.-Pipeline Analysis 20

Genocea Biosciences, Inc.-Pipeline Products by Route of Administration 20

Genocea Biosciences, Inc.-Pipeline Products by Molecule Type 21

Genocea Biosciences, Inc.-Recent Pipeline Updates 22

Genocea Biosciences, Inc.-Dormant Projects 27

Genocea Biosciences, Inc.-Locations And Subsidiaries 28

Head Office 28

Appendix 29

Methodology 29

Coverage 29

Secondary Research 29

Primary Research 29

Expert Panel Validation 29

Contact Us 29

Disclaimer 30

List of Tables

Genocea Biosciences, Inc., Key Information 5

Genocea Biosciences, Inc., Key Facts 5

Genocea Biosciences, Inc.-Pipeline by Indication, 2015 7

Genocea Biosciences, Inc.-Pipeline by Stage of Development, 2015 8

Genocea Biosciences, Inc.-Monotherapy Products in Pipeline, 2015 9

Genocea Biosciences, Inc.-Phase II, 2015 10

Genocea Biosciences, Inc.-Preclinical, 2015 11

Genocea Biosciences, Inc.-Discovery, 2015 12

Genocea Biosciences, Inc.-Pipeline by Route of Administration, 2015 20

Genocea Biosciences, Inc.-Pipeline by Molecule Type, 2015 21

Genocea Biosciences, Inc.-Recent Pipeline Updates, 2015 22

Genocea Biosciences, Inc.-Dormant Developmental Projects,2015 27

List of Figures

Genocea Biosciences, Inc.-Pipeline by Top 10 Indication, 2015 7

Genocea Biosciences, Inc.-Pipeline by Stage of Development, 2015 8

Genocea Biosciences, Inc.-Monotherapy Products in Pipeline, 2015 9

Genocea Biosciences, Inc.-Pipeline by Top 10 Molecule Type, 2015 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Genocea Biosciences, Inc.; Genocea Biosciences, Inc. - Key Therapeutics; Genocea Biosciences, Inc. - Pipeline Overview and Promising Molecules; Genocea Biosciences, Inc. - News; Genocea Biosciences, Inc. - Latest Updates; Genocea Biosciences, Inc. - Pipeline; Genocea Biosciences, Inc. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com